Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2R,4E)-2-aminooctadec-4-en-1-ol | compound displays significant anti-protozoal effects at the concentrations analyzed | Leishmania major | |
additional information | synthesis of ceramide derivatives built around a set of hydroxybutenyl amine cores, exploring variations in the sphingosine tail, N-acyl unit and the degree of hydroxylation. The N-acyl chain contributes to affinity, analogues lacking the amide linkage function as competitive inhibitors in both enzyme and cell-based assays | Leishmania major | |
N-[(2R,4E)-1-hydroxyoctadec-4-en-2-yl]-2-phenylacetamide | - |
Leishmania major | |
N-[(2S,4E)-3-hydroxyoctadec-4-en-2-yl]octanamide | - |
Leishmania major |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania major | E9AFX2 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-phosphatidyl-1D-myo-inositol + N-[(2R,4E)-1-hydroxyoctadec-4-en-2-yl]octanamide | - |
Leishmania major | 1,2-diacyl-sn-glycerol + ? | - |
? | |
additional information | synthesis of ceramide derivatives built around a set of hydroxybutenyl amine cores, exploring variations in the sphingosine tail, N-acyl unit and the degree of hydroxylation. The C-3 hydroxyl group is not essential for turnover but it provides enhanced affinity. A long (C13) hydrocarbon ceramide tail is necessary for both high affinity and turnover. The N-acyl chain also contributes to affinity, analogues lacking the amide linkage function as competitive inhibitors in both enzyme and cell-based assays | Leishmania major | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
IPCS | - |
Leishmania major |
LMJF_35_4990 | - |
Leishmania major |
phosphatidylinositol:ceramide inositolphosphotransferase | - |
Leishmania major |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0048 | - |
pH not specified in the publication, temperature not specified in the publication | Leishmania major | N-[(2S,4E)-3-hydroxyoctadec-4-en-2-yl]octanamide | |
0.0132 | - |
pH not specified in the publication, temperature not specified in the publication | Leishmania major | N-[(2R,4E)-1-hydroxyoctadec-4-en-2-yl]-2-phenylacetamide | |
0.0147 | - |
pH not specified in the publication, temperature not specified in the publication | Leishmania major | (2R,4E)-2-aminooctadec-4-en-1-ol |